Skip to main content
Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: PCSK9 inhibitors for secondary prevention in patients with cardiovascular diseases: a bayesian network meta-analysis

Fig. 5

Network analysis for secondary safety outcomes. A The forest plot for injection site reaction. B The SUCRA value of each treatment for injection site reaction. C The forest plot for new-onset diabetes. D The SUCRA value of each treatment for new-onset diabetes. E The forest plot for neurocognitive disorders. F The SUCRA value of each treatment for neurocognitive disorders. CrI credible interval, SUCRA surface under the cumulative ranking curve

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840